search
attachments
weblink
advanced
Overview
Content Tools
Activity
| Name | Size | Creator | Creation Date | Last Modification Date | Labels | Attached To |
|---|---|---|---|---|---|---|
| Budwig_Compilation.pdf | 394 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 19, 2015 17:14 | Jan 19, 2015 17:15 | Budwig Protocol | |
| Flax Oil as a true aid.pdf | 1.02 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 19, 2015 17:12 | Jan 19, 2015 17:12 | Budwig Protocol | |
| Erlotinib (Tarceva) | 767 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 19, 2015 13:30 | Jan 19, 2015 14:13 | Tarceva | |
| Overall survival analyses of first-line erlotinib | 154 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 19, 2015 14:10 | Jan 19, 2015 14:12 | Tarceva | |
| Tarceva Promo Material.pdf | 1.49 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 19, 2015 14:10 | Jan 19, 2015 14:10 | Tarceva | |
| Target Binding Properties and Cellular Activity of… | 1.91 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:37 | Jan 13, 2015 18:55 | Targeted Therapy | |
| LUX-Lung 4: A Phase II Trial of Afatinib in Patien… | 129 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:37 | Jan 13, 2015 18:55 | Targeted Therapy | |
| Re-Treatment with EGFR-TKIs in NSCLC Patients Who … | 464 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:37 | Jan 13, 2015 18:54 | Targeted Therapy | |
| Epidermal growth factor receptor (EGFR) mutations … | 778 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:33 | Jan 13, 2015 18:54 | Targeted Therapy | |
| PIIS2211124714003015.pdf | 3.72 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:37 | Jan 13, 2015 18:37 | Targeted Therapy | |
| PIIS0305737214001200.pdf | 420 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:37 | Jan 13, 2015 18:37 | Targeted Therapy | |
| fonc-04-00350.pdf | 1.29 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:33 | Jan 13, 2015 18:33 | Targeted Therapy | |
| BTT-40567-clinical-and-comparative-utility-of-afat… | 273 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:33 | Jan 13, 2015 18:33 | Targeted Therapy | |
| 40-49 TLCR-2012-44.pdf | 381 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:33 | Jan 13, 2015 18:33 | Targeted Therapy | |
| 2213-0802-2-2.pdf | 430 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:33 | Jan 13, 2015 18:33 | Targeted Therapy | |
| 1-s2.0-S1574789111001451-main.pdf | 584 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 18:32 | Jan 13, 2015 18:32 | Targeted Therapy | |
| Immunologic and Clinical Effects of Targeting PD-1… | 531 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 04:36 | Jan 13, 2015 05:25 | Immunotherapy | |
| Immune Checkpoint Inhibitors: Making Immunotherapy… | 451 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 04:35 | Jan 13, 2015 05:24 | Immunotherapy | |
| Gerson Therapy Handbook 5th-revision | 25.82 MB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 04:51 | Jan 13, 2015 05:22 | Gerson Therapy | |
| Cooking for the Gerson Therapy | 476 kB | Unknown User (alin314_1@touchstonenetwork.net) | Jan 13, 2015 04:51 | Jan 13, 2015 05:21 | Gerson Therapy |